Sacral Neuromodulation System Market - Global Outlook and Forecast 2023-2028

Report ID: 1371369 | Published Date: Jan 2025 | No. of Page: 66 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Sacral Neuromodulation System Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Sacral Neuromodulation System Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Sacral Neuromodulation System Overall Market Size
    2.1 Global Sacral Neuromodulation System Market Size: 2021 VS 2028
    2.2 Global Sacral Neuromodulation System Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Sacral Neuromodulation System Players in Global Market
    3.2 Top Global Sacral Neuromodulation System Companies Ranked by Revenue
    3.3 Global Sacral Neuromodulation System Revenue by Companies
    3.4 Top 3 and Top 5 Sacral Neuromodulation System Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Sacral Neuromodulation System Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Sacral Neuromodulation System Players in Global Market
        3.6.1 List of Global Tier 1 Sacral Neuromodulation System Companies
        3.6.2 List of Global Tier 2 and Tier 3 Sacral Neuromodulation System Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Sacral Neuromodulation System Market Size Markets, 2021 & 2028
        4.1.2 Internal Neuromodulation System
        4.1.3 External Neuromodulation System
    4.2 By Type - Global Sacral Neuromodulation System Revenue & Forecasts
        4.2.1 By Type - Global Sacral Neuromodulation System Revenue, 2017-2022
        4.2.2 By Type - Global Sacral Neuromodulation System Revenue, 2023-2028
        4.2.3 By Type - Global Sacral Neuromodulation System Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Sacral Neuromodulation System Market Size, 2021 & 2028
        5.1.2 Spinal Cord Stimulation
        5.1.3 Deep Brain Stimulation
        5.1.4 Sacral Nerve Stimulation
        5.1.5 Vagus Nerve Stimulation
    5.2 By Application - Global Sacral Neuromodulation System Revenue & Forecasts
        5.2.1 By Application - Global Sacral Neuromodulation System Revenue, 2017-2022
        5.2.2 By Application - Global Sacral Neuromodulation System Revenue, 2023-2028
        5.2.3 By Application - Global Sacral Neuromodulation System Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Sacral Neuromodulation System Market Size, 2021 & 2028
    6.2 By Region - Global Sacral Neuromodulation System Revenue & Forecasts
        6.2.1 By Region - Global Sacral Neuromodulation System Revenue, 2017-2022
        6.2.2 By Region - Global Sacral Neuromodulation System Revenue, 2023-2028
        6.2.3 By Region - Global Sacral Neuromodulation System Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Sacral Neuromodulation System Revenue, 2017-2028
        6.3.2 US Sacral Neuromodulation System Market Size, 2017-2028
        6.3.3 Canada Sacral Neuromodulation System Market Size, 2017-2028
        6.3.4 Mexico Sacral Neuromodulation System Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Sacral Neuromodulation System Revenue, 2017-2028
        6.4.2 Germany Sacral Neuromodulation System Market Size, 2017-2028
        6.4.3 France Sacral Neuromodulation System Market Size, 2017-2028
        6.4.4 U.K. Sacral Neuromodulation System Market Size, 2017-2028
        6.4.5 Italy Sacral Neuromodulation System Market Size, 2017-2028
        6.4.6 Russia Sacral Neuromodulation System Market Size, 2017-2028
        6.4.7 Nordic Countries Sacral Neuromodulation System Market Size, 2017-2028
        6.4.8 Benelux Sacral Neuromodulation System Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Sacral Neuromodulation System Revenue, 2017-2028
        6.5.2 China Sacral Neuromodulation System Market Size, 2017-2028
        6.5.3 Japan Sacral Neuromodulation System Market Size, 2017-2028
        6.5.4 South Korea Sacral Neuromodulation System Market Size, 2017-2028
        6.5.5 Southeast Asia Sacral Neuromodulation System Market Size, 2017-2028
        6.5.6 India Sacral Neuromodulation System Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Sacral Neuromodulation System Revenue, 2017-2028
        6.6.2 Brazil Sacral Neuromodulation System Market Size, 2017-2028
        6.6.3 Argentina Sacral Neuromodulation System Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Sacral Neuromodulation System Revenue, 2017-2028
        6.7.2 Turkey Sacral Neuromodulation System Market Size, 2017-2028
        6.7.3 Israel Sacral Neuromodulation System Market Size, 2017-2028
        6.7.4 Saudi Arabia Sacral Neuromodulation System Market Size, 2017-2028
        6.7.5 UAE Sacral Neuromodulation System Market Size, 2017-2028
7 Players Profiles
    7.1 Medtronic, Inc. (US)
        7.1.1 Medtronic, Inc. (US) Corporate Summary
        7.1.2 Medtronic, Inc. (US) Business Overview
        7.1.3 Medtronic, Inc. (US) Sacral Neuromodulation System Major Product Offerings
        7.1.4 Medtronic, Inc. (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.1.5 Medtronic, Inc. (US) Key News
    7.2 Boston Scientific Corporation (US)
        7.2.1 Boston Scientific Corporation (US) Corporate Summary
        7.2.2 Boston Scientific Corporation (US) Business Overview
        7.2.3 Boston Scientific Corporation (US) Sacral Neuromodulation System Major Product Offerings
        7.2.4 Boston Scientific Corporation (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.2.5 Boston Scientific Corporation (US) Key News
    7.3 St. Jude Medical, Inc. (US)
        7.3.1 St. Jude Medical, Inc. (US) Corporate Summary
        7.3.2 St. Jude Medical, Inc. (US) Business Overview
        7.3.3 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Major Product Offerings
        7.3.4 St. Jude Medical, Inc. (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.3.5 St. Jude Medical, Inc. (US) Key News
    7.4 Synapse Biomedical, Inc. (US)
        7.4.1 Synapse Biomedical, Inc. (US) Corporate Summary
        7.4.2 Synapse Biomedical, Inc. (US) Business Overview
        7.4.3 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Major Product Offerings
        7.4.4 Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.4.5 Synapse Biomedical, Inc. (US) Key News
    7.5 Nevro Corporation (US)
        7.5.1 Nevro Corporation (US) Corporate Summary
        7.5.2 Nevro Corporation (US) Business Overview
        7.5.3 Nevro Corporation (US) Sacral Neuromodulation System Major Product Offerings
        7.5.4 Nevro Corporation (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.5.5 Nevro Corporation (US) Key News
    7.6 Neurosigma, Inc. (US)
        7.6.1 Neurosigma, Inc. (US) Corporate Summary
        7.6.2 Neurosigma, Inc. (US) Business Overview
        7.6.3 Neurosigma, Inc. (US) Sacral Neuromodulation System Major Product Offerings
        7.6.4 Neurosigma, Inc. (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.6.5 Neurosigma, Inc. (US) Key News
    7.7 Neuropace, Inc. (US)
        7.7.1 Neuropace, Inc. (US) Corporate Summary
        7.7.2 Neuropace, Inc. (US) Business Overview
        7.7.3 Neuropace, Inc. (US) Sacral Neuromodulation System Major Product Offerings
        7.7.4 Neuropace, Inc. (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.7.5 Neuropace, Inc. (US) Key News
    7.8 Neuronetics, Inc. (US)
        7.8.1 Neuronetics, Inc. (US) Corporate Summary
        7.8.2 Neuronetics, Inc. (US) Business Overview
        7.8.3 Neuronetics, Inc. (US) Sacral Neuromodulation System Major Product Offerings
        7.8.4 Neuronetics, Inc. (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.8.5 Neuronetics, Inc. (US) Key News
    7.9 Cyberonics, Inc. (US)
        7.9.1 Cyberonics, Inc. (US) Corporate Summary
        7.9.2 Cyberonics, Inc. (US) Business Overview
        7.9.3 Cyberonics, Inc. (US) Sacral Neuromodulation System Major Product Offerings
        7.9.4 Cyberonics, Inc. (US) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.9.5 Cyberonics, Inc. (US) Key News
    7.10 BioControl Medical (Israel)
        7.10.1 BioControl Medical (Israel) Corporate Summary
        7.10.2 BioControl Medical (Israel) Business Overview
        7.10.3 BioControl Medical (Israel) Sacral Neuromodulation System Major Product Offerings
        7.10.4 BioControl Medical (Israel) Sacral Neuromodulation System Revenue in Global Market (2017-2022)
        7.10.5 BioControl Medical (Israel) Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Sacral Neuromodulation System Market Opportunities & Trends in Global Market
    Table 2. Sacral Neuromodulation System Market Drivers in Global Market
    Table 3. Sacral Neuromodulation System Market Restraints in Global Market
    Table 4. Key Players of Sacral Neuromodulation System in Global Market
    Table 5. Top Sacral Neuromodulation System Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Sacral Neuromodulation System Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Sacral Neuromodulation System Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Sacral Neuromodulation System Product Type
    Table 9. List of Global Tier 1 Sacral Neuromodulation System Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Sacral Neuromodulation System Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Sacral Neuromodulation System Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Sacral Neuromodulation System Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Sacral Neuromodulation System Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Sacral Neuromodulation System Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Sacral Neuromodulation System Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Sacral Neuromodulation System Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Sacral Neuromodulation System Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Sacral Neuromodulation System Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Sacral Neuromodulation System Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Sacral Neuromodulation System Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Sacral Neuromodulation System Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Sacral Neuromodulation System Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Sacral Neuromodulation System Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Sacral Neuromodulation System Revenue, (US$, Mn), 2023-2028
    Table 30. Medtronic, Inc. (US) Corporate Summary
    Table 31. Medtronic, Inc. (US) Sacral Neuromodulation System Product Offerings
    Table 32. Medtronic, Inc. (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 33. Boston Scientific Corporation (US) Corporate Summary
    Table 34. Boston Scientific Corporation (US) Sacral Neuromodulation System Product Offerings
    Table 35. Boston Scientific Corporation (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 36. St. Jude Medical, Inc. (US) Corporate Summary
    Table 37. St. Jude Medical, Inc. (US) Sacral Neuromodulation System Product Offerings
    Table 38. St. Jude Medical, Inc. (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 39. Synapse Biomedical, Inc. (US) Corporate Summary
    Table 40. Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Product Offerings
    Table 41. Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 42. Nevro Corporation (US) Corporate Summary
    Table 43. Nevro Corporation (US) Sacral Neuromodulation System Product Offerings
    Table 44. Nevro Corporation (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 45. Neurosigma, Inc. (US) Corporate Summary
    Table 46. Neurosigma, Inc. (US) Sacral Neuromodulation System Product Offerings
    Table 47. Neurosigma, Inc. (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 48. Neuropace, Inc. (US) Corporate Summary
    Table 49. Neuropace, Inc. (US) Sacral Neuromodulation System Product Offerings
    Table 50. Neuropace, Inc. (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 51. Neuronetics, Inc. (US) Corporate Summary
    Table 52. Neuronetics, Inc. (US) Sacral Neuromodulation System Product Offerings
    Table 53. Neuronetics, Inc. (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 54. Cyberonics, Inc. (US) Corporate Summary
    Table 55. Cyberonics, Inc. (US) Sacral Neuromodulation System Product Offerings
    Table 56. Cyberonics, Inc. (US) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
    Table 57. BioControl Medical (Israel) Corporate Summary
    Table 58. BioControl Medical (Israel) Sacral Neuromodulation System Product Offerings
    Table 59. BioControl Medical (Israel) Sacral Neuromodulation System Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Sacral Neuromodulation System Segment by Type in 2021
    Figure 2. Sacral Neuromodulation System Segment by Application in 2021
    Figure 3. Global Sacral Neuromodulation System Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Sacral Neuromodulation System Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Sacral Neuromodulation System Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Sacral Neuromodulation System Revenue in 2021
    Figure 8. By Type - Global Sacral Neuromodulation System Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Sacral Neuromodulation System Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Sacral Neuromodulation System Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Sacral Neuromodulation System Revenue Market Share, 2017-2028
    Figure 12. US Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Sacral Neuromodulation System Revenue Market Share, 2017-2028
    Figure 16. Germany Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 17. France Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Sacral Neuromodulation System Revenue Market Share, 2017-2028
    Figure 24. China Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 28. India Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Sacral Neuromodulation System Revenue Market Share, 2017-2028
    Figure 30. Brazil Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Sacral Neuromodulation System Revenue Market Share, 2017-2028
    Figure 33. Turkey Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Sacral Neuromodulation System Revenue, (US$, Mn), 2017-2028
    Figure 37. Medtronic, Inc. (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Boston Scientific Corporation (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. St. Jude Medical, Inc. (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Synapse Biomedical, Inc. (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Nevro Corporation (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Neurosigma, Inc. (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Neuropace, Inc. (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Neuronetics, Inc. (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Cyberonics, Inc. (US) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. BioControl Medical (Israel) Sacral Neuromodulation System Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Sacral Neuromodulation System Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Sacral Neuromodulation System Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Sacral Neuromodulation System Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports